Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Never miss an Options trading signal: Unusual Options Activity and Options Screeners with Barchart Premier. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Tempus Ai Cl A (TEM)

Tempus Ai Cl A (TEM)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 13,638,350
  • Shares Outstanding, K 177,907
  • Annual Sales, $ 693,400 K
  • Annual Income, $ -705,810 K
  • EBIT $ -242 M
  • EBITDA $ -198 M
  • 60-Month Beta 4.99
  • Price/Sales 19.58
  • Price/Cash Flow N/A
  • Price/Book 26.74

Options Overview Details

View History
  • Implied Volatility 64.50% (+2.00%)
  • Historical Volatility 64.02%
  • IV Percentile 1%
  • IV Rank 2.80%
  • IV High 133.93% on 04/08/25
  • IV Low 62.49% on 12/04/25
  • Expected Move (DTE 5) 4.55 (5.93%)
  • Put/Call Vol Ratio 0.47
  • Today's Volume 15,328
  • Volume Avg (30-Day) 20,555
  • Put/Call OI Ratio 0.59
  • Today's Open Interest 369,307
  • Open Int (30-Day) 374,766
  • Expected Range 72.11 to 81.21

Analyst Rating / Earnings Estimates

Current Rating
See More
Moderate Buy
Based on 15 analysts offering recommendations.
Earnings Estimates - Current Qtr 12/31/25
See More
  • Average Estimate -0.28
  • Number of Estimates 5
  • High Estimate -0.25
  • Low Estimate -0.33
  • Prior Year -0.33
  • Growth Rate Est. (year over year) +15.15%

Price Performance

See More
Period Period Low Period High Performance
1-Month
64.20 +19.41%
on 11/18/25
80.40 -4.65%
on 11/06/25
-5.60 (-6.81%)
since 11/05/25
3-Month
64.20 +19.41%
on 11/18/25
104.32 -26.51%
on 10/09/25
-2.96 (-3.72%)
since 09/05/25
52-Week
31.36 +144.45%
on 01/13/25
104.32 -26.51%
on 10/09/25
+23.50 (+44.21%)
since 12/05/24

Most Recent Stories

More News
AI-Powered Platforms Accelerate Healthcare's Preventative Care Wellness Revolution

Issued on behalf of Aleen Inc. VANCOUVER – Baystreet.ca News Commentary – The artificial intelligence in healthcare market is projected to expand from $17.2 billion in 2025 to $77.2 billion...

AIDX.TO : 0.94 (unch)
HWAIF : 0.6867 (+1.43%)
WELL.TO : 3.96 (-0.75%)
RXRX : 4.71 (-4.27%)
TEM : 76.66 (+0.43%)
WHTCF : 2.8700 (+1.77%)
ALEN-U.CN : 1.3400 (unch)
AI-Powered Platforms Scale as Preventive Care and Biomarker Testing Converge

VANCOUVER – Baystreet.ca News Commentary – Healthcare providers are prioritizing preventive care strategies as nearly 58% now integrate biomarker testing into early wellness indicators [1], a shift...

HIMS : 39.20 (-2.05%)
TEM : 76.66 (+0.43%)
WHWK : 2.49 (-2.73%)
BFLY : 3.06 (unch)
ALEN-U.CN : 1.3400 (unch)
Tempus to Participate in the Piper Sandler 37th Annual Healthcare Conference

Tempus AI, Inc. (NASDAQ: TEM), a leader in artificial intelligence and precision medicine, today announced that it will participate in the Piper Sandler 37th Annual Healthcare Conference on Wednesday,...

TEM : 76.66 (+0.43%)
Tempus and IFLI Announce Study to Advance Follicular Lymphoma Research

Tempus Launches Its First Study With a Nonprofit Foundation Collaborator to Create Robust FL Dataset

TEM : 76.66 (+0.43%)
Tempus AI: Volatility Equates to Opportunity in AI Leader

Tempus AI is well-positioned to accelerate growth as its investments in healthcare-focused AI pay off. Analysts are raising their targets.

TEM : 76.66 (+0.43%)
Tempus Announces Six Abstracts Accepted for Presentation at the Society for Immunotherapy of Cancer Annual Meeting 2025

Tempus AI, Inc. (NASDAQ: TEM), a technology company leading the adoption of AI to advance precision medicine, today announced that six abstracts have been accepted for presentation at the Society for Immunotherapy...

TEM : 76.66 (+0.43%)
Tempus: Q3 Earnings Snapshot

Tempus: Q3 Earnings Snapshot

TEM : 76.66 (+0.43%)
Tempus Reports Third Quarter 2025 Results

Tempus AI, Inc. (NASDAQ: TEM), a technology company leading the adoption of AI to advance precision medicine and patient care, today reported financial results for the quarter ended September 30, 2025. ...

TEM : 76.66 (+0.43%)
Funding Is Back in Digital Health, Marking Move into AI Wellness Renaissance

Issued on behalf of Aleen Inc. VANCOUVER – Baystreet.ca News Commentary – So far, the latest Q3 funding surge[1] has shown digital wellness building speed again as investors are backing AI...

CCLD : 3.11 (-0.96%)
TEM : 76.66 (+0.43%)
WHWK : 2.49 (-2.73%)
WAY : 34.35 (-2.97%)
ALEN-U.CN : 1.3400 (unch)
Tempus to Participate in the Stifel 2025 Healthcare Conference

Tempus AI, Inc. (NASDAQ: TEM), a leader in artificial intelligence and precision medicine, today announced that it will participate in the Stifel 2025 Healthcare Conference on Thursday, November 13 in...

TEM : 76.66 (+0.43%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 24% Buy with a Weakening short term outlook on maintaining the current direction.

See More Share

Business Summary

Tempus AI Inc. is a technology company advancing precision medicine through the practical application of artificial intelligence principally in healthcare. The company provides AI-enabled precision medicine solutions to physicians to deliver personalized patient care and in parallel facilitates discovery,...

See More

Key Turning Points

3rd Resistance Point 81.18
2nd Resistance Point 79.52
1st Resistance Point 78.09
Last Price 76.66
1st Support Level 75.00
2nd Support Level 73.34
3rd Support Level 71.91

See More

52-Week High 104.32
Last Price 76.66
Fibonacci 61.8% 76.45
Fibonacci 50% 67.84
Fibonacci 38.2% 59.23
52-Week Low 31.36

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar